HIV expression levels ex vivo: a surrogate marker for clinical endpoints in the evaluation of AIDS treatments?
Mathez, D.; Paul, D.; Bélilovsky, C.; Sultan, Y.; Gorin, I.; Deleuze, J.; Saurin, W.; Decker, R.; Leibowitch, J.
Developments in Biological Standardization 72: 299-304
1990
ISSN/ISBN: 0301-5149 PMID: 2282988 Document Number: 347778
Document emailed within 1 workday
Related Documents
Lazebnik, L.B.; Gusein-Zade, M.G.; Efremov, L.I. 2011: Selection of "surrogate" and "endpoints" evaluation of the efficacy of medical interventions Eksperimental'naia i Klinicheskaia Gastroenterologiia 2011(8): 73-79Furrer, H. 1998: Surrogate endpoints in clinical studies exemplified by HIV infection Schweizerische Medizinische Wochenschrift 128(27-28): 1079-1088
Nakajima, T.; Ohta, K.; Ohyama, S.; Yamaguchi, T. 2000: Surrogate and true endpoints in cancer clinical trials Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(5): 671-675
Jin, P.; Li, J.; Zhou, Y.; Zhu, F. 2015: Immunological surrogate endpoints to evaluate vaccine efficacy Zhonghua Yu Fang Yi Xue Za Zhi 49(12): 1110-1114
Scheinin, N.M.; Scheinin, M.; Rinne, J.O. 2011: Amyloid imaging as a surrogate marker in clinical trials in Alzheimer's disease Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 55(3): 265-279
2005: Insulin in type 2 diabetes: a useful alternative despite limited assessment based on surrogate endpoints Prescrire International 14(79): 187-193
Alam, I.; Alam, I.; Ali, I.; Ali, M. 2014: Weight loss in HCV patients can be used as a surrogate marker for evaluation of interferon (IFN-α) treatment efficacy - a prospective pilot study Pakistan Journal of Pharmaceutical Sciences 27(3): 571-576
Jibrin, Y.B.; Yusuph, H.; Garbati, M.A.; Gashau, W.; Abja, U.M.A. 2006: Should absolute lymphocyte count be used as a surrogate marker for CD4+ count in patients with HIV/AIDS? African Journal of Medicine and Medical Sciences 35(1): 9-13
Denis, G.; Humblet, C.; Verlaet, M.; Boniver, J.; Defresne, M.P. 1998: p53, Bax and Bcl-2 in vivo expression in the murine thymus after apoptogenic treatments Anticancer Research 18(5a): 3315-3321
Acharyya, S.; Sau, S.; Dasgupta, P.; Chakraborty, A.; Gangopadhyay, S. 2012: Skin rash as a surrogate marker of clinical response of targeted therapy using gefitinib in advanced or metastatic non-small-cell lung cancer--a retrospective study Journal of the Indian Medical Association 110(7): 474-6 493
Okochi, M.; Tagami, S.; Yanagida, K.; Takeda, M. 2010: Surrogate marker for ABeta42 Nihon Shinkei Seishin Yakurigaku Zasshi 30(4): 169-172
Vainas, I.; Koussis, C.; Pazaitou-Panayiotou, K.; Drimonitis, A.; Chrisoulidou, A.; Iakovou, I.; Boudina, M.; Kaprara, A.; Maladaki, A. 2004: Somatostatin receptor expression in vivo and response to somatostatin analog therapy with or without other antineoplastic treatments in advanced medullary thyroid carcinoma Journal of Experimental and Clinical Cancer Research: Cr 23(4): 549-559
Jain, G.; Devpura, G.; Gupta, B.S. 2009: Abnormalities in the thyroid function tests as surrogate marker of advancing HIV infection in infected adults Journal of the Association of Physicians of India 57: 508-510
Ulich, T.R.; Guo, K.Z.; Remick, D.; del Castillo, J.; Yin, S.M. 1991: Endotoxin-induced cytokine gene expression in vivo. III. IL-6 mRNA and serum protein expression and the in vivo hematologic effects of IL-6 Journal of Immunology 146(7): 2316-2323
Abra, R.M.; Schreier, H.; Szoka, F.C. 1982: The use of a new radioactive-iodine labeled lipid marker to follow in vivo disposition of liposomes: comparison with an encapsulated aqueous space marker Research Communications in Chemical Pathology and Pharmacology 37(2): 199-213
Cowen, E.; Maddix, J. 1990: An evaluation of a workplace aids education intervention program focusing on hiv knowledge levels and attitudes toward gay men and people with aids Sixth International Conference on Aids Sixth International Conference on Aids, Vols 1-3 Pagination Varies Sixth International Conference on Aids University Of California San Francisco: San Francisco, California, Usa Illus Maps Paper : abstract Thd 216
Cowen, E.; Maddix, J. 1990: An evaluation of a workplace aids education intervention program focusing on hiv knowledge levels and attitudes toward gay men and people with aids Sixth International Conference on Aids Sixth International Conference on Aids, Vols 1-3 Pagination Varies Sixth International Conference on Aids University Of California San Francisco: San Francisco, California, Usa Illus Maps Paper : abstract Thd 216
Hutchinson, G. 2005: HIV mania as a marker for clinical deterioration in AIDS West Indian Medical Journal 54(2): 149-151
De Jong, M.A.; Wisaksana, R.; Meijerink, H.; Indrati, A.; van de Ven, A.J.A.M.; Alisjahbana, B.; van Crevel, R. 2012: Total lymphocyte count is a reliable surrogate marker for CD4 cell counts after the first year of antiretroviral therapy: data from an Indonesian cohort study Tropical Medicine and International Health: Tm and Ih 17(5): 581-583
Elliott, H.L. 1998: Endothelial dysfunction in cardiovascular disease: risk factor, risk marker, or surrogate end point? Journal of Cardiovascular Pharmacology 32(Suppl 3): S74-S77